PeerView Press - Thought leader views and opinions on current clinical advances in medicine
   CME/CE Topics
All Topics
AIDS/HIV
Cardiology
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatic/Biliary Disorders
Neurology
Oncology
Ophthalmology
Psychiatry
Pulmonology
Rheumatology
Other Topics
Faculty
Podcasts
About Us
Contact Us
      Considering EGFR Inhibitors for Treatment
of SCCHN

      Podcast on iTunes.  (What is podcasting?)
 Related Articles          


      Course Director
Merrill S. Kies, MD

2006-08-21
Audio - EGFR-Directed Therapy in Combination With Radiotherapy Shows Promise in Head and Neck Cancer EGFR-Directed Therapy in Combination With Radiotherapy Shows Promise in Head and Neck Cancer  CME/CE
James A. Bonner, MD
University of Alabama at Birmingham
Birmingham, Alabama
Download this presentation's materials
Slides
Printable Transcript
MP3
 
Audio - Combined Treatment Modalities Demonstrate Activity in Treatment of Squamous Cell Carcinoma of the Head and Neck Combined Treatment Modalities Demonstrate Activity in Treatment of Squamous Cell Carcinoma of the Head and Neck  CME/CE
Merrill S. Kies, MD
University of Texas M. D. Anderson Cancer Center
Houston, Texas
Download this presentation's materials
Slides
Printable Transcript
MP3
 
Audio - Epidermal Growth Factor Receptor Inhibitors Are Changing Practice Patterns in Treating Head and Neck Cancer Epidermal Growth Factor Receptor Inhibitors Are Changing Practice Patterns in Treating Head and Neck Cancer  CME/CE
Ezra Cohen, MD
University of Chicago
Chicago, Illinois
Download this presentation's materials
Slides
Printable Transcript
MP3
 
Audio - Optimizing the Therapeutic Index Improves Survival and Quality of Life in Head and Neck Cancer Optimizing the Therapeutic Index Improves Survival and Quality of Life in Head and Neck Cancer  CME/CE
David I. Rosenthal, MD
University of Texas M. D. Anderson Cancer Center
Houston, Texas
Download this presentation's materials
Slides
Printable Transcript
MP3
  Request a CD-ROM - Considering EGFR Inhibitors for Treatment of SCCHN

      Credit Available: US Physicians - 1.0 AMA PRA Category 1 Credit(s)™.
US Nurses – 1.2 contact hour(s).

Release Date: August 21, 2006; Valid for credit through
August 20, 2007.

CME/CE in this activity indicates continuing education for medical professionals.

     
CME/CE Information
General Information
Faculty and Disclosure Statements
Target Audience
Program Description
Educational Objectives
 		Accreditation and Credit Designation Statements
Hardware/Software Requirements
Privacy Policy
Post-Test & Evaluation
This CME/CE activity, which indicates continuing education for medical professionals, has been planned and produced in accordance with the ACCME and ANCC COA Essential Areas and Policies.
     
This CME/CE activity is jointly sponsored by The University of Michigan Medical School, Amedco, LLC, and PVI, PeerView Institute for Medical Education.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its supporters.


Warning / Disclaimer  Privacy Policy
Copyright © 2000-2008, PeerView Press - Medical Education Resource
Sign-up for FREE E-mail Alerts